Evidence-based opioid detox with MAT options including Suboxone and methadone.
Opioid addiction — whether from prescription painkillers, heroin, or fentanyl — has become one of the most pressing public health challenges in the United States. Effective treatment begins with medically managed detoxification, followed by ongoing medication-assisted treatment (MAT) and behavioral therapy.
National Detox Centers connects individuals struggling with opioid addiction to detox programs that use FDA-approved medications to manage withdrawal and support long-term recovery.
Suboxone is a partial opioid agonist that reduces cravings and withdrawal symptoms without producing the euphoria associated with full agonist opioids. It can be prescribed in office-based settings, making it accessible for outpatient treatment. Suboxone treatment has been shown to significantly reduce illicit opioid use, improve treatment retention, and decrease overdose risk.
Methadone is a long-acting full opioid agonist dispensed through licensed methadone clinics. It eliminates withdrawal symptoms and reduces cravings for 24 to 36 hours. Methadone maintenance treatment is one of the most extensively studied approaches to opioid addiction and has decades of evidence supporting its effectiveness.
Vivitrol is a monthly injection of naltrexone, an opioid antagonist that blocks the effects of opioids. Unlike Suboxone and methadone, Vivitrol requires complete detox from opioids before starting treatment. It is most appropriate for patients who have completed detox and are committed to abstinence-based recovery.
Which MAT option is right for you? Our intake specialists can help determine the best medication-assisted treatment approach based on your individual situation. Call (866) 409-8060 for a confidential assessment.
Opioid detox typically lasts 5 to 7 days for short-acting opioids (heroin, oxycodone) and 7 to 14 days for long-acting opioids (methadone, extended-release formulations). During detox, medical staff will initiate medication-assisted treatment, manage withdrawal symptoms, monitor for complications, and begin developing a continuing care plan.